Newsletter | December 16, 2025

12.16.25 -- Considerations In Sterility Testing And Assurance

SPONSOR

The 2026 ISPE Facilities of the Future Conference, 2-3 February, in San Diego, California, will explore regulatory compliance, workforce development, how digital tools are transforming manufacturing facilities, sustainability and facility design, and how companies are building flexibility and resilience into future facility plans. Technical tracks include: Compliance and Quality, Digital Transformation, AI Integration, and the Future Workforce, Facility Design, and Innovative Manufacturing and Sustainability. Learn more

INDUSTRY INSIGHTS

Calculating The ROI Of EAM/CMMS For Pharma Manufacturers And CDMOs

Learn how EAM and CMMS systems help pharma manufacturers reduce risk, improve compliance, and cut costs, as well as nine signs it’s time to move beyond outdated asset management practices.

Safely Navigating The Transition From MDD To MDR

If devices are integral to positive patient outcomes, device partners must play an integral role to ensure regulatory compliance is achieved in the most effective way.

Solutions In Pre-Filled Syringes For Biologics And Ophthalmic Applications

Discover how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.

FEATURED EDITORIAL

Considerations In Sterility Testing And Assurance

Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety.

INDUSTRY INSIGHTS CONTINUED

Handling Protocols: Key Considerations In The Highly Potent API Market

Uncover the growing role of highly potent active pharmaceutical ingredients in oncology and Antibody-Drug Conjugates to highlight manufacturing challenges, safety protocols, and opportunities for CDMOs.

How Compliance-Driven CDMOs Win Sponsor Contracts

See how evolving global regulations are reshaping CDMO strategy. and how digital infrastructure helps manufacturers stay audit-ready, build sponsor trust, and turn compliance into an advantage.

A Blueprint For Breakthroughs: Accelerating Rare Disease Therapies

To manufacture your rare disease therapy cost effectively, partner with an experienced CDMO from the outset. The right partner will offer development, manufacturing, quality, and regulatory expertise.

What Does Annex 1 Mean For Cryovial Filling?

New sterile manufacturing rules require major changes to cryovial filling. Ensure compliance by adopting better "first-air" protection, minimizing human contact, and using 100% dose checks.

Automated Immunoassay For AAV Capsid Titer Measurement

Find out how automated immunoassays outperform ELISA in AAV quantitation—offering better sensitivity and precision to help you identify the best media for high viral titers.

Optimizing The Path To First-In-Human Clinical Trials: Design And De-Risk

Examine the ways to design and de-risk molecules, streamlining the path to GMP manufacturing and clinical trials, and case studies that provide insight into key activities.

Overcoming Challenges To High-Concentration Formulation Development

Gain insight into a platform that optimizes high-concentration therapeutic antibody formulations, as well as overcomes stability and manufacturability challenges to deliver safe, effective therapies.

Overcoming Limitations To Achieve Uniform Dosing

An immediate need for lower dose capsules in the clinic posed several challenges in blend formulation with very tight timelines for delivery.

ITC For Binding Characterization In Pharmaceutical Research

Discover an Isothermal Titration Calorimetry tool that is precise for characterizing molecular interactions, which is crucial for drug discovery and lead optimization in pharmaceutical research.

Inclusion Bodies: Mother Nature's Help Or Hindrance?

Hear about strategies that improve the performance of IB processes as well as the pros and cons of soluble and insoluble processes: isolating, solubilizing, and properly refolding.

Advancing Patient-Centric Drug Delivery For Neurodegenerative Disease

Pharmaceutical companies must prioritize patient-centric dosage forms to address challenges like dysphagia, enhance medication compliance, and improve therapeutic outcomes.

Discover How Our Polyurethanes Can Enhance Your Medical Device Designs

Review a family of medical-grade polyurethanes that are engineered for high performance, biocompatibility, and reliability in advanced, critical medical device applications.

Animal-Origin Free Peptones In Cell Culture Media For Vaccine Manufacturing

Investigate the impact of peptone supplementation on adenovirus and VSV production, highlighting its potential to reduce serum dependency in cell culture media. 

SOLUTIONS

Achieve GxP Compliance With Confidence: A Practical Framework

The Industrial DataOps Solution For Industry 4.0

Change Management Program For Cleaning And Disinfection

Does Blow/Fill/Seal Aseptic Packaging Make Sense for Your Drug?

High Voltage Leak Detection Systems For Syringes

Drug Product Filtration System

Tablet Metal Detector For Pharmaceutical And Nutraceutical Production

Human ADME Studies: Human Metabolism Data For Regulatory Submission

Connect With Pharmaceutical Online: